Local Institution - 0013

Toronto, Ontario M5G 1X5

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Colorectal Cancer

Studies at this site

• A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) — Running, not enrolling